Advertisement

U.S. Markets closed

S&P Futures
6,004.75
+1.00(+0.02%)
Dow Futures
43,924.00
+14.00(+0.03%)
Nasdaq Futures
21,223.25
-1.50(-0.01%)
Russell 2000 Futures
2,399.30
+3.60(+0.15%)
Crude Oil
72.10
-0.26(-0.36%)
Gold
2,708.20
+2.40(+0.09%)

Bicycle Therapeutics PLC (50BA.SG)

Stuttgart - Stuttgart Delayed Price. Currency in EUR

21.20

-0.60

(-2.75%)

At close: 11:34AM CET

Loading interactive chart...

Simply Wall St.
Bicycle Therapeutics Third Quarter 2024 Earnings: EPS Beats Expectations, Revenues Lag
Bicycle Therapeutics ( NASDAQ:BCYC ) Third Quarter 2024 Results Key Financial Results Revenue: US$2.68m (down 50% from...
Business Wire
Bicycle Therapeutics Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
CAMBRIDGE, England & BOSTON, November 01, 2024--Bicycle Therapeutics plc (NASDAQ: BCYC), today announced that on November 1, 2024, the Compensation Committee of the company’s Board of Directors granted to twelve new employees inducement awards consisting of non-qualified share options to purchase an aggregate of 56,700 ordinary shares. These awards were made under Bicycle Therapeutics’ 2024 Inducement Plan and approved by the Compensation Committee as an inducement material to the employees ente